Curis
CRIS
#11244
Rank
C$2.03 M
Marketcap
C$0.84
Share price
9.39%
Change (1 day)
-59.84%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$20.42

According to Curis's latest financial reports the company's current EPS (TTM) is C-$19.87. In 2025 the company made an earnings per share (EPS) of C-$33.27 an increase over its 2024 EPS that were of C-$196.46.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$20.42-38.61%
2025C-$33.27-83.07%
2024C-$196.46-22.15%
2023C-$252.35-26.17%
2022C-$341.7822.3%
2021C-$279.46-25.37%
2020C-$374.48-30.93%
2019C-$542.15-2.02%
2018C-$553.33
2016C-$1,258-10%
2015C-$1,397138.1%
2014C-$586.8740%
2013C-$419.19-25%
2012C-$558.9266.67%
2011C-$335.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.06-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.34-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.61-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.08-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$4.44-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$4.81-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA